Cited by 336Lipoproteins and Cardiovascular HealthCholesterol and Lipid MetabolismParaoxonase enzyme and polymorphisms

The DOI matches its Crossref record; 279 of the 282 references it cites were found in a registry or an index.

High-density lipoproteins: A consensus statement from the National Lipid Association

Toth, Peter P., Barter, Philip J., Rosenson, Robert S., Boden, William E., Chapman, M. John, Cuchel, Marina, D'Agostino, Ralph B., Davidson, Michael H., Davidson, W. Sean, Heinecke, Jay W., Karas, Richard H., Kontush, Anatol, Krauss, Ronald M., Miller, Michael, Rader, Daniel J.·2013·Journal of Clinical Lipidology

DOI 10.1016/j.jacl.2013.08.001

Open this paper in CoChat — free account

Abstract

For >4 decades it has been recognized that elevated serum levels of high-density lipoprotein cholesterol (HDL-C) are associated with reduced risk of cardiovascular disease (CVD) and its sequelae. Many prospective observational studies performed around the world have confirmed an inverse relationship between HDL-C and cardiovascular risk in people irrespective of sex, race, or ethnicity. Consequently, it was assumed that, by extension, raising HDL-C through lifestyle modification and pharmacologic intervention would reduce risk of CVD. Animal studies are consistent with this assumption. Lipid treatment guidelines around the world promoted the recognition of HDL-C as a therapeutic target, especially in high-risk patients. Some post hoc analyses from randomized controlled trials also suggest that raising HDL-C beneficially affects the risk of CVD. However, a number of recent randomized studies putatively designed to test the "HDL hypothesis" have failed to show benefit. The results of these trials have caused many clinicians to question whether HDL-C is a legitimate therapeutic target. In response to the many questions and uncertainties raised by the results of these trials, the National Lipid Association convened an expert panel to evaluate the current status of HDL-C as a therapeutic target; to review the current state of knowledge of HDL particle structure, composition, and function; and to identify the salient questions yet to be answered about the role of HDL in either preventing or contributing to atherosclerotic disease. The expert panel's conclusions and clinical recommendations are summarized herein. The panel concludes that, although low HDL-C identifies patients at elevated risk, and much investigation suggests that HDL may play a variety of antiatherogenic roles, HDL-C is not a therapeutic target at the present time. Risk stratified atherogenic lipoprotein burden (low-density lipoprotein cholesterol and non-HDL-C) should remain the primary and secondary targets of therapy in patients at risk, as described by established guidelines. The National Lipid Association emphasizes that rigorous research into the biology and clinical significance of low HDL-C should continue. The development of novel drugs designed to modulate the serum levels and functionality of HDL particles should also continue. On the basis of an enormous amount of basic scientific and clinical investigation, a considerable number of reasons support the need to continue to investigate the therapeutic effect of modulating HDL structure and function.

Integrity signals

Registry

Crossref · 10.1016/j.jacl.2013.08.001

Cites

279 of 279 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM
Havel, R. J., Eder, H. A., & Bragdon, J. H. (1955) · Journal of Clinical Investigation · doi:10.1172/jci103182 · Cited by 8,737
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
Self-citation
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
Cholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550
Heart Disease and Stroke Statistics—2011 Update: A Report From the American Heart Association
Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Adams, R. J., Berry, J. D., Brown, T. M., Carnethon, M. R., Dai, S., de Simone, G., Ford, E. S., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182009701 · Cited by 6,149
High density lipoprotein as a protective factor against coronary heart disease
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881 · cited 1×
“This possibility was further supported in the primary prevention Helsinki Heart Study (HHS) in which a 1% increase in HDL-C with gemfibrozil was associated with a 3% decrease in CVD events.(34) Another randomized controlled trial that tested the fibric acid gemfibrozil was the Veterans Affairs HDL Intervention Trial (…”
Result

Show all 282 references

Research works printed but not linked: 3

Voight, 2012, Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study, Lancet, 380, 572, 10.1016/S0140-6736(12)60312-2 · DOI · Paper page
Morse, 2001, Niacin plus simvastatin protect against atherosclerosis progression and clinical events in CAD patients with low HDL-C and diabetes mellitus or impaired fasting glucose, J Am Coll Cardiol, 37, 262A
Kannel, 1992, Efficacy of lipid profiles in prediction of coronary disease, Am Heart J, 124, 768, 10.1016/0002-8703(92)90288-7 · DOI

Sorted by citations

Items 101–200 of 336

Current and future therapies for addressing the effects of inflammation on HDL cholesterol metabolism
Iqbal, F., Baker, W. S., Khan, M. I., Thukuntla, S., McKinney, K. H., Abate, N. I., & Tuvdendorj, D. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13743 · Cited by 32
Genetic control of the mouse HDL proteome defines HDL traits, function, and heterogeneity
Pamir, N., Pan, C., Plubell, D. L., Hutchins, P. M., Tang, C., Wimberger, J., Irwin, A. D., Vallim, T. Q. D. A., Heinecke, J. W., & Lusis, A. J. (2019) · Journal of Lipid Research · doi:10.1194/jlr.m090555 · Cited by 29
Self-citation
Spectrum of Apolipoprotein AI and Apolipoprotein AII Proteoforms and Their Associations With Indices of Cardiometabolic Health: The CARDIA Study
Wilkins, J., Seckler, H. S., Rink, J., Compton, P. D., Fornelli, L., Thaxton, C., LeDuc, R. D., Jacobs, D., Doubleday, P., Sniderman, A., et al. (2021) · Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease · doi:10.1161/jaha.120.019890 · Cited by 20
Understanding Myeloperoxidase-Induced Damage to HDL Structure and Function in the Vessel Wall: Implications for HDL-Based Therapies
Marsche, G., Stadler, J. T., Kargl, J., & Holzer, M. (2022) · Antioxidants · doi:10.3390/antiox11030556 · Cited by 30
Non-Coding RNAs in Regulating Plaque Progression and Remodeling of Extracellular Matrix in Atherosclerosis
Singh, D., Rai, V., & Agrawal, D. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213731 · Cited by 29
Model Membranes and Their Interactions with Native and Artificial Lipoproteins
Waldie, S. (2020) · doi:10.24834/isbn.9789178771325 · Cited by 28
An Experimentally Robust Model of Monomeric Apolipoprotein A-I Created from a Chimera of Two X-ray Structures and Molecular Dynamics Simulations
Segrest, J. P., Jones, M. K., Shao, B., & Heinecke, J. W. (2014) · Biochemistry · doi:10.1021/bi501111j · Cited by 27
Self-citation
An evaluation of pitavastatin for the treatment of hypercholesterolemia
Chan, P., Shao, L., Tomlinson, B., Zhang, Y., & Liu, Z.-M. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1544243 · Cited by 27
Subfractions of high-density lipoprotein (HDL) and dysfunctional HDL in chronic kidney disease patients
Rysz-Górzyńska, M., & Banach, M. (2016) · Archives of Medical Science · doi:10.5114/aoms.2016.60971 · Cited by 25
Whole egg consumption compared with yolk-free egg increases the cholesterol efflux capacity of high-density lipoproteins in overweight, postmenopausal women
Sawrey‐Kubicek, L., Zhu, C., Bardagjy, A. S., Rhodes, C. H., Sacchi, R., Randolph, J., Steinberg, F. M., & Zivkovic, A. M. (2019) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqz088 · Cited by 26
Inflammation in Atherosclerosis
Lauterbach, M., Labzin, L. I., & Latz, E. (2017) · Wiley-VCH eBooks · doi:10.1002/9783527692156.ch49 · Cited by 26
Cholesterol transport and beyond: Illuminating the versatile functions of HDL apolipoproteins through structural insights and functional implications
Bhale, A. S., Meilhac, O., d’Hellencourt, C. L., Vijayalakshmi, M. A., & Venkataraman, K. (2024) · BioFactors · doi:10.1002/biof.2057 · Cited by 27
Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs
KONES, R. J., & Rumana, U. (2015) · Drugs · doi:10.1007/s40265-015-0429-3 · Cited by 26
Monocyte to high-density lipoprotein ratio predict long-term clinical outcomes in patients with coronary heart disease: A meta-analysis of 9 studies
Liu, H., Jiang, Z.-H., Yang, Z.-B., & Quan, X. (2022) · Medicine · doi:10.1097/md.0000000000030109 · Cited by 24
Twelve months of exercise training did not halt abdominal aortic calcification in patients with CKD – a sub-study of RENEXC-a randomized controlled trial
Zhou, Y., Hellberg, M., Hellmark, T., Höglund, P., & Clyne, N. (2020) · BMC Nephrology · doi:10.1186/s12882-020-01881-y · Cited by 23
Size, density and cholesterol load of HDL predict microangiopathy, coronary artery disease and β-cell function in men with T2DM
Hermans, M. P., Amoussou-Guenou, K. D., Bouénizabila, E., Sadikot, S. S., Ahn, S. A., & Rousseau, M. F. (2016) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2016.08.029 · Cited by 23
Reduced high-density lipoprotein cholesterol: A valuable, independent prognostic marker in peripheral arterial disease
Martínez-Aguilar, E., Orbe, J., Fernández‐Montero, A., Fernandez-Alonso, S., Rodríguez, J. A., Fernandez‐Alonso, L., Páramo, J. A., & Roncal, C. (2017) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2017.04.056 · Cited by 23
Sex steroids mediate discrete effects on HDL cholesterol efflux capacity and particle concentration in healthy men
Rubinow, K. B., Vaisar, T., Chao, J. H., Heinecke, J. W., & Page, S. T. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.04.013 · Cited by 23
Self-citation
HDL-C and Cardiovascular Risk: You Don't Need to Worry about Extremely High HDL-C Levels
Cho, Y. K., & Jung, C. H. (2021) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2021.10.1.57 · Cited by 26
Biomarkers in Pulmonary Arterial Hypertension
Hojda, S.-E., Chiş, I. C., & Clichici, S. V. (2022) · Diagnostics · doi:10.3390/diagnostics12123033 · Cited by 22
Extended-Release Niacin Versus Fenofibrate in HIV-Infected Participants With Low High-Density Lipoprotein Cholesterol: Effects on Endothelial Function, Lipoproteins, and Inflammation
Dubé, M. P., Komarow, L., Fichtenbaum, C. J., Cadden, J. J., Overton, E. T., Hodis, H. N., Currier, J. S., & Stein, J. H. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ385 · Cited by 22
Proteome Dynamics Reveals Pro-Inflammatory Remodeling of Plasma Proteome in a Mouse Model of NAFLD
Li, L., Bebek, G., Previs, S. F., Smith, J. D., Sadygov, R. G., McCullough, A. J., Willard, B. B., & Kasumov, T. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00601 · Cited by 22
Positive association of familial longevity with the moderate-high HDL-C concentration in Bama Aging Study
Wang, J., Shi, L., Zou, Y., Tang, J., Cai, J., Wei, Y., Qin, J., & Zhang, Z. (2018) · Aging · doi:10.18632/aging.101663 · Cited by 22
Comparative transcriptomics reveals domestication‐associated features of Atlantic salmon lipid metabolism
Jin, Y. O., Olsen, R. E., Harvey, T. N., Östensen, M., Li, K., Santi, N., Vadstein, Ô., Bones, A. M., Vik, J. O., Sandve, S. R., et al. (2020) · Molecular Ecology · doi:10.1111/mec.15446 · Cited by 22
Antipsoriatic treatment extends beyond the skin: recovering of high‐density lipoprotein function
Marsche, G., Holzer, M., & Wolf, P. (2014) · Experimental Dermatology · doi:10.1111/exd.12483 · Cited by 22
High-density lipoprotein particle concentration and subclinical atherosclerosis of the carotid arteries in Japanese men
Zaid, M., Fujiyoshi, A., Miura, K., Abbott, R. D., Okamura, T., Takashima, N., Torii, S., Saito, Y., Hisamatsu, T., Miyagawa, N., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.01.031 · Cited by 20
Evidence for the atherogenic index of plasma as a potential biomarker for cardiovascular disease in schizophrenia
Önen, S., & Taymur, İ. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211026450 · Cited by 19
Risk factor profile by etiological subtype of ischemic stroke in the young.
Jaffre, A., Ruidavets, J., Calvière, L., Viguier, A., Ferrières, J., & Larrue, V. (2014) · Clinical neurology and neurosurgery (Dutch-Flemish ed. Print) · doi:10.1016/j.clineuro.2014.02.017 · Cited by 24
Spotlight on HDL biology: new insights in metabolism, function, and translation
Rader, D. J. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu164 · Cited by 21
Self-citation
JCL roundtable: High-density lipoprotein function and reverse cholesterol transport
Cuchel, M., Rohatgi, A. K., Sacks, F. M., & Guyton, J. R. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.09.005 · Cited by 21
Self-citation
Hyperlipidemia‐induced hepatic and small intestine ER stress and decreased paraoxonase 1 expression and activity is associated with HDL dysfunction in Syrian hamsters
Stancu, C. S., Carnuta, M. G., Sanda, G. M., Toma, L., Deleanu, M., Niculescu, L. S., Sasson, S., Simionescu, M., & Sima, A. V. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500422 · Cited by 21
Maternal Phytosterol Supplementation during Pregnancy and Lactation Modulates Lipid and Lipoprotein Response in Offspring of apoE-Deficient Mice
Rideout, T. C., Movsesian, C., Tsai, Y.-T., Iqbal, A., Raslawsky, A., & Patel, M. S. (2015) · Journal of Nutrition · doi:10.3945/jn.115.215061 · Cited by 20
A fast semi-quantitative LC–MS method for measurement of intact apolipoprotein A-I reveals novel proteoforms in serum
Gåfvels, M. E., & Bengtson, P. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.01.011 · Cited by 20
Effects of testosterone supplementation therapy on lipid metabolism in hypogonadal men with T2 DM : a meta‐analysis of randomized controlled trials
Zhang, K., Zhao, M. ‐., An, Q., Jia, Y., Fu, L., Xu, J., & Gu, Y. (2017) · Andrology · doi:10.1111/andr.12425 · Cited by 21
A high-fat/high-cholesterol diet, but not high-cholesterol alone, increases free cholesterol and apoE-rich HDL serum levels in rats and upregulates hepatic ABCA1 expression
Shinohata, R., Shibakura, M., Arao, Y., Watanabe, S., Hirohata, S., & Usui, S. (2022) · Biochimie · doi:10.1016/j.biochi.2022.01.011 · Cited by 21
Genetic analysis of long-lived families reveals novel variants influencing high density-lipoprotein cholesterol
Feitosa, M. F., Wojczynski, M. K., Straka, R. J., Kammerer, C. M., Lee, J. H., Kraja, A. T., Christensen, K., Newman, A. B., Province, M. A., & Borecki, I. B. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00159 · Cited by 19
Association of plasminogen activator inhibitor-1 and low-density lipoprotein heterogeneity as a risk factor of atherosclerotic cardiovascular disease with triglyceride metabolic disorder
Iida, K., Tani, S., Atsumi, W., Yagi, T., Kawauchi, K., Matsumoto, N., & Hirayama, A. (2017) · Coronary Artery Disease · doi:10.1097/mca.0000000000000521 · Cited by 19
Lipid-modifying therapy in chronic kidney disease: Pathophysiological and clinical considerations
Heine, G. H., Eller, K., Stadler, J. T., Rogacev, K. S., & Marsche, G. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107459 · Cited by 19
Factors influencing dyslipidemia in statin-treated patients in Lebanon and Jordan: results of the Dyslipidemia International Study
Bramlage, P., Azar, S. T., Okkeh, O., Brudi, P., Ambegaonkar, B. M., Abu-Hantash, H., Jambart, S., Zaheri, M., Rachoin, R., Chafoun, A., et al. (2014) · Vascular Health and Risk Management · doi:10.2147/vhrm.s57194 · Cited by 19
The Effect of High Carbohydrate-to-fat Intake Ratios on Hypo-HDL-cholesterolemia Risk and HDL-cholesterol Levels over a 12-year Follow-up
Lee, H. A., & An, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-57931-w · Cited by 18
HDL-cholesterol concentration and its association with coronary artery calcification: a systematic review and meta-analysis
Abedi, F., Sadeghi, M., Omidkhoda, N., Kelesidis, T., Ramezani, J., Samadi, S., & Mohammadpour, A. H. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01827-x · Cited by 18
Plasma lipoproteins in posttraumatic stress disorder patients compared to healthy controls and their associations with the HPA- and HPT-axis
de Vries, G., Mocking, R. J. T., Assies, J., Schene, A. H., & Olff, M. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.09.020 · Cited by 18
Infusions of Large Synthetic HDL Containing Trimeric apoA-I Stabilize Atherosclerotic Plaques in Hypercholesterolemic Rabbits
Parolini, C., Adorni, M. P., Busnelli, M., Manzini, S., Cipollari, E., Favari, E., Lorenzon, P., Ganzetti, G. S., Fingerle, J., Bernini, F., et al. (2019) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2019.05.033 · Cited by 19
Temporal Dynamics of High-Density Lipoprotein Proteome in Diet-Controlled Subjects with Type 2 Diabetes
Kheniser, K. G., Ösme, A., Kim, C., Ilchenko, S., Kasumov, T., & Kashyap, S. R. (2020) · Biomolecules · doi:10.3390/biom10040520 · Cited by 19
Sex-Related Differences of the Effect of Lipoproteins and Apolipoproteins on 10-Year Cardiovascular Disease Risk; Insights from the ATTICA Study (2002–2012)
Kouvari, M., Panagiotakos, D. B., Chrysohoou, C. A., Georgousopoulou, E. N., Tousoulis, D. M., & Pitsavos, C. E. (2020) · Molecules · doi:10.3390/molecules25071506 · Cited by 19
Genomic and transcriptomic predictors of triglyceride response to regular exercise
Sarzynski, M. A., Davidsen, P. K., Sung, Y. J., Hesselink, M. K. C., Schrauwen, P., Rice, T., Rao, D. C., Falciani, F., & Bouchard, C. (2015) · British Journal of Sports Medicine · doi:10.1136/bjsports-2015-095179 · Cited by 18
Magnesium Levels Modify the Effect of Lipid Parameters on Carotid Intima Media Thickness
Cambray, S., Ibarz, M., Bermúdez-López, M., Martí-Antonio, M., Božić, M., Fernández, E., & Valdivielso, J. M. (2020) · Nutrients · doi:10.3390/nu12092631 · Cited by 17
Moderate alcohol consumption and lipoprotein subfractions: a systematic review of intervention and observational studies
Wilkens, T. L., Tranæs, K., Eriksen, J. N., & Dragsted, L. O. (2021) · Nutrition Reviews · doi:10.1093/nutrit/nuab102 · Cited by 18
Low HDL Cholesterol Efflux Capacity Indicates a Fatal Course of COVID-19
Stadler, J. T., Mangge, H., Rani, A., Curcic, P., Herrmann, M., Prüller, F., & Marsche, G. (2022) · Antioxidants · doi:10.3390/antiox11101858 · Cited by 17
Early Prediction of Left Ventricular Reverse Remodeling in First-Diagnosed Idiopathic Dilated Cardiomyopathy: A Comparison of Linear Model, Random Forest, and Extreme Gradient Boosting
Xie, X., Yang, M., Xie, S., Wu, X., Jiang, Y., Liu, Z., Zhao, H., Chen, Y., Zhang, Y., & Wang, J. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.684004 · Cited by 17
The effect of different types of exercise on blood lipid profiles: A meta-analysis of randomized controlled studies
Buzdağlı, Y., Tekin, A., Eyipınar, C. D., Öget, F., & Şıktar, E. (2022) · Science & Sports · doi:10.1016/j.scispo.2022.07.005 · Cited by 22
Targeting High-Density Lipoproteins: Increasing De Novo Production Versus Decreasing Clearance
Mooradian, A. D., & Haas, M. J. (2015) · Drugs · doi:10.1007/s40265-015-0390-1 · Cited by 16
Effects of weight change on HDL-cholesterol and its subfractions in over 28,000 men and women
Dansinger, M. L., Williams, P. T., Superko, H. R., Asztalos, B. F., & Schaefer, E. J. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.12.001 · Cited by 16
High Free Cholesterol Bioavailability Drives the Tissue Pathologies in Scarb1 −/− Mice
Liu, J., Gillard, B. K., Yelamanchili, D., Gotto, A. M., Rosales, C., & Pownall, H. J. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.316535 · Cited by 16
Lack of ApoA-I in ApoEKO Mice Causes Skin Xanthomas, Worsening of Inflammation, and Increased Coronary Atherosclerosis in the Absence of Hyperlipidemia
Busnelli, M., Manzini, S., Colombo, A., Franchi, E., Bonacina, F., Chiara, M., Arnaboldi, F., Donetti, E., Ambrogi, F., Oleari, R., et al. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.122.317790 · Cited by 15
Monocyte-to-High Density Lipoprotein Cholesterol Ratio Positively Predicts Coronary Artery Disease and Multi-Vessel Lesions in Acute Coronary Syndrome
Du, G., Liu, F., Liu, H., Meng, Q., Tang, R., Li, X., Yang, Y., & Gao, X.-M. (2023) · International Journal of General Medicine · doi:10.2147/ijgm.s419579 · Cited by 16
Nascent HDL (High-Density Lipoprotein) Discs Carry Cholesterol to HDL Spheres
Navdaev, A. V., Sborgi, L., Wright, S. D., & Didichenko, S. A. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.313906 · Cited by 15
HDL in CKD
de Boer, I. H., & Brunzell, J. D. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014010062 · Cited by 15
Hepatic FoxOs link insulin signaling with plasma lipoprotein metabolism through an apolipoprotein M/sphingosine-1-phosphate pathway
Izquierdo, M. C., Shanmugarajah, N., Lee, S. X., Kraakman, M. J., Westerterp, M., Kitamoto, T., Harris, M., Cook, J. R., Gusarova, G. A., Zhong, K., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci146219 · Cited by 15
Review of Laboratory Methods to Determine HDL and LDL Subclasses and Their Clinical Importance
Chary, A., & Hedayati, M. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2304147 · Cited by 15
V-ATPase (Vacuolar ATPase) Activity Required for ABCA1 (ATP-Binding Cassette Protein A1)-Mediated Cholesterol Efflux
Lorkowski, S. W., Brubaker, G., Gulshan, K., & Smith, J. D. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311814 · Cited by 16
Diagnosis and Management of Dyslipidemia
Myerson, M. L. (2019) · Springer eBooks · doi:10.1007/978-3-030-10451-1_3 · Cited by 14
High-density lipoprotein cholesterol levels are associated with coronary severity but not with outcomes in new-onset patients with stable coronary artery disease
Liu, H., Guo, Y., Wu, N., Zhu, C., Gao, Y., Qing, P., Li, S., Zhao, X., Zhang, Y., Sun, D., et al. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.06.013 · Cited by 14
USF1 deficiency alleviates inflammation, enhances cholesterol efflux and prevents cholesterol accumulation in macrophages
Ruuth, M. K., Soronen, J., Kaiharju, E., Merikanto, K., Perttilä, J., Metso, J., Lee‐Rueckert, M., Taskinen, M., Kovanen, P. T., Öörni, K., et al. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0930-2 · Cited by 14
Is HPS2-THRIVE the death knell for niacin?
Toth, P. P., Murthy, A., Sidhu, M. S., & Boden, W. E. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.01.008 · Cited by 13
Self-citation
Current Drug Treatment of Hyperlipidemia in Older Adults
Dixon, D. L., Donohoe, K. L., Ogbonna, K. C., & Barden, S. M. (2015) · Drugs & Aging · doi:10.1007/s40266-015-0240-6 · Cited by 13
Hypertriglyceridaemia, Postprandial Lipaemia and Non-HDL Cholesterol
Stefanutti, C., Labbadia, G., & Athyros, V. G. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140620120130 · Cited by 14
Perimenopausal transdermal estradiol replacement reduces serum HDL cholesterol efflux capacity but improves cardiovascular risk factors
Vaisar, T., Gordon, J. L., Wimberger, J., Heinecke, J. W., Hinderliter, A. L., Rubinow, D. R., Girdler, S. S., & Rubinow, K. B. (2020) · Journal of clinical lipidology · doi:10.1016/j.jacl.2020.11.009 · Cited by 13
Self-citation
ApoE and ApoE Nascent-Like HDL Particles at Model Cellular Membranes: Effect of Protein Isoform and Membrane Composition
Waldie, S., Sebastiani, F., Moulin, M., Giudice, R. D., Paracini, N., Roosen-Runge, F., Gerelli, Y., Prévost, S., Voss, J., Darwish, T., et al. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.630152 · Cited by 9
Deficiency of proline/serine-rich coiled-coil protein 1 (PSRC1) accelerates trimethylamine N-oxide-induced atherosclerosis in ApoE−/− mice
Luo, T., Liu, D., Guo, Z., Chen, P., Guo, Z., Ou, C., & Chen, M. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.05.013 · Cited by 13
Humoral Immunity Against HDL Particle: A New Perspective in Cardiovascular Diseases?
Satta, N., Frias, M. A., Vuilleumier, N., & Pagano, S. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190830164917 · Cited by 14
Cardiovascular risk profile of patients with atherogenic dyslipidemia in middle age Lithuanian population
Kutkienė, S., Petrulionienė, Ž., Laucevičius, A., Matuzevičienė, G., Kasiulevičius, V., Petrulionytė, E., Staigytė, J., Saulyte, A., Gargalskaite, U., Skiauterytė, E., et al. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0851-0 · Cited by 13
The Alcohol–High-Density Lipoprotein Athero-Protective Axis
Rosales, C., Gillard, B. K., Gotto, A. M., & Pownall, H. J. (2020) · Biomolecules · doi:10.3390/biom10070987 · Cited by 13
Association of Short-Term Exposure to PM2.5 with Blood Lipids and the Modification Effects of Insulin Resistance: A Panel Study in Wuhan
Sun, J., Peng, S., Li, Z., Liu, F., Wu, C., Lu, Y., & Xiang, H. (2022) · Toxics · doi:10.3390/toxics10110663 · Cited by 12
Lipid Management in Human Immunodeficiency Virus
Myerson, M. L. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.09.010 · Cited by 12
Associations of HDL metrics with coronary artery calcium score and density among women traversing menopause
Khoudary, S. R. E., Nasr, A., Matthews, K. A., Orchard, T. J., Brooks, M. M., Billheimer, J. T., McConnell, D. S., Janssen, İ., Everson‐Rose, S. A., Crawford, S. L., et al. (2021) · Journal of Lipid Research · doi:10.1016/j.jlr.2021.100098 · Cited by 12
Self-citation
Association between different cutoff points for objectively measured moderate-to-vigorous physical activity and cardiometabolic markers in older adults
dos Santos, C. E. S., d’Orsi, E., & Rech, C. R. (2020) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2020.104238 · Cited by 10
Perspective The failure of cholesteryl ester transfer protein inhibitors: is it due to increased blood viscosity?
Sloop, G. D., Weidman, J. J., & Cyr, J. A. S. (2015) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944714566427 · Cited by 12
Novel polymorphisms associated with hyperalphalipoproteinemia and apparent cardioprotection
Oates, C. P., Koenig, D., Rhyne, J., Bogush, N., O’Connell, J. R., Mitchell, B. D., & Miller, M. J. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.10.021 · Cited by 11
Self-citation
Methanol extract of Erythrina senegalensis leaves (MEES) ameliorates Plasmodium berghei-ANKA 65-parasitised aberrations in mice
Joshua, P. E., Okoro, I. J., Ekpo, D. E., Okagu, I. U., & Ogugua, V. N. (2020) · All Life · doi:10.1080/26895293.2020.1718777 · Cited by 11
HDL from apoA1 transgenic mice expressing the 4WF isoform is resistant to oxidative loss of function
Berisha, S. Z., Brubaker, G., Kasumov, T., Hung, K. T., DiBello, P. M., Huang, Y. R., Li, L., Willard, B. B., Pollard, K. A., Nagy, L. E., et al. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m056754 · Cited by 11
Spleen Size Does Not Correlate With Histological Stage of Liver Disease in People With Nonalcoholic Fatty Liver Disease
Cacciottolo, T. M., Kumar, A., Godfrey, E. M., Davies, S. E., & Allison, M. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.01.007 · Cited by 10
HDL Function Versus Small Dense LDL: Cardiovascular Benefits and Implications
Stoicescu, C. I., Văcărescu, C., & Cozma, D. C. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14144945 · Cited by 11
HDL-C, longitudinal change and risk of mortality in a Chinese cohort study
Yang, Z., Wu, M., Lu, J., Zhu, Y., Li, D., Yu, Z., Shen, P., Tang, M., Jin, M., Lin, H., et al. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.06.004 · Cited by 10
Association of breastfeeding duration with dyslipidemia in women aged over 20 years: Korea National Health and Nutrition Examination Survey 2010–2014
Cho, S., & Han, E. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.01.009 · Cited by 11
Effect of chicken egg yolk immunoglobulins on serum biochemical profiles and intestinal bacterial populations in early‐weaned piglets
Tan, X., Li, J., Li, Y., Li, J., Wang, Q., Fang, L., Ding, X., Huang, P., Yang, H., & Yin, Y. (2019) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/jpn.13129 · Cited by 10
Further proof of a paradoxical relationship between high-density lipoprotein levels and adverse cardiovascular outcomes: are there implications for cardiovascular disease prevention?
Kunutsor, S. K., & Laukkanen, J. A. (2022) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwac272 · Cited by 10
High-density lipoproteins. Part 2. Impact of disease states on functionality
Gluba-Brzózka, A., Olszewski, R., Franczyk, B., Młynarska, E., Rysz-Górzyńska, M., Rysz, J., Surma, S., Sheth, S., Banach, M., & Toth, P. P. (2025) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2025.101073 · Cited by 12
Self-citation
High-density lipoprotein in cardiovascular diseases: From high quantity to high quality
Zhang, Y., Yu, M., Chen, Y., & Huang, J. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120574 · Cited by 10
Sphingomyelin regulation of plasma membrane asymmetry, efflux and reverse cholesterol transport
Gulshan, K., & Smith, J. D. (2014) · Clinical Lipidology · doi:10.2217/clp.14.28 · Cited by 9
Cardiovascular Disease as a Result of the Interactions Between Obesity, Climate Change, and Inflammation: The COCCI Syndemic
Clearfield, M. B., Davis, G. E., Weis, J., Gayer, G. G., & Shubrook, J. H. (2018) · Journal of Osteopathic Medicine · doi:10.7556/jaoa.2018.157 · Cited by 10
Safety assessment and antimalarial property of methanol extract of Fagara zanthoxyloides root-bark on Plasmodium berghei-infected mice
Amah, C. C., Enechi, O. C., Ekpo, D. E., Okagu, I. U., Ononiwu, C. P., & Joshua, P. E. (2021) · Comparative Clinical Pathology · doi:10.1007/s00580-021-03202-7 · Cited by 9
A self-selected 16:8 time-restricted eating quasi-experimental intervention improves various markers of cardiovascular health in middle-age male cyclists
Waldman, H. S., Witt, C. R., Grozier, C. D., & McAllister, M. J. (2023) · Nutrition · doi:10.1016/j.nut.2023.112086 · Cited by 8
Dynamic Resistance Exercise Alters Blood ApoA-I Levels, Inflammatory Markers, and Metabolic Syndrome Markers in Elderly Women
Ahn, N., & Kim, K. (2022) · Healthcare · doi:10.3390/healthcare10101982 · Cited by 8
Revisiting “Good” and “Bad” Cholesterol. The Battle over Flow through Arteries Now Shifts to Flow through Airways
Fessler, M. B. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201502-0413ed · Cited by 8
Metabolismus und Funktion der Lipoproteine hoher Dichte (HDL)
Jomard, A., & Osto, E. (2019) · Praxis · doi:10.1024/1661-8157/a003241 · Cited by 8
Preβ1-high-density lipoprotein metabolism is delayed in patients with chronic kidney disease not on hemodialysis
Yamatani, K., Hirayama, S., Seino, U., Hirayama, A., Hori, A., Suzuki, K., Idei, M., Kitahara, M., & Miida, T. (2020) · Journal of clinical lipidology · doi:10.1016/j.jacl.2020.07.011 · Cited by 8
Association of High-Density Lipoprotein Cholesterol Phenotypes with the Risk of Cardiovascular Diseases and Mortality: A Cohort Study in Korea
Nam, G. E., Huh, Y., Jung, J., Han, K., Kim, S. M., & on Behalf of the Taskforce Team of the Obesity Fact Sheet of the Korean Society for the Study of Obesity (2022) · Endocrinology and Metabolism · doi:10.3803/enm.2021.1259 · Cited by 10
Alcohol Consumption, High-Density Lipoprotein Particles and Subspecies, and Risk of Cardiovascular Disease: Findings from the PREVEND Prospective Study
Kunutsor, S., Bhattacharjee, A., Connelly, M., Bakker, S. J., & Dullaart, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042290 · Cited by 8
Are HDL levels lower in children with type 1 diabetes and concurrent celiac disease compared with children with type 1 diabetes only?
Jessup, A. B., Law, J. R., & Spagnoli, A. (2014) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2013-0464 · Cited by 8

Authors: Toth, P. P., Barter, P. J., Rosenson, R. S., Boden, W. E., Chapman, M. J., Cuchel, M., D'Agostino, R. B., Davidson, M. H., Davidson, W. S., Heinecke, J. W., Karas, R. H., Kontush, A., Krauss, R. M., Miller, M., & Rader, D. J.
Affiliations: CGH Medical Center (US)
The Heart Research Institute (AU)
Icahn School of Medicine at Mount Sinai (US)
Albany Medical College (US)
Inserm (FR)
University of Pennsylvania (US)
University of Chicago (US)
University of Cincinnati (US)
University of Washington (US)
Tufts University (US)
University of California, San Francisco (US)
University of Maryland, Baltimore (US)
Corresponding author: Toth, Peter P.
ORCID: Toth, Peter P.
Rosenson, Robert S.
Boden, William E.
Chapman, M. John
Cuchel, Marina
Davidson, Michael H.
Davidson, W. Sean
Heinecke, Jay W.
Karas, Richard H.
Kontush, Anatol
Krauss, Ronald M.
Miller, Michael
Rader, Daniel J.
Venue: Journal of Clinical Lipidology
Publisher: Elsevier BV
Published: 2013-09
Volume: 7
Issue: 5
Pages: 484-525
ISSN: 1876-4789 (ISSN-L)
1933-2874
DOI: 10.1016/j.jacl.2013.08.001
OpenAlex: W2106601510
Cited by: 336
References: 282
Citations by year: 2026: 6 · 2025: 21 · 2024: 10 · 2023: 21 · 2022: 34 · 2021: 24 · 2020: 38 · 2019: 25 · 2018: 28 · 2017: 26 · 2016: 19 · 2015: 41 · 2014: 41 · 2013: 2
FWCI: 33.82
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Journal of clinical lipidology (publishedVersion)
PubMed (publishedVersion)
Funders: National Heart, Lung, and Blood Institute (R01HL112625)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
Keywords: HDL cholesterol, cardiovascular risk, atherosclerosis, LDL cholesterol, non-HDL cholesterol, risk stratification
MeSH terms: Animals, Cardiovascular Diseases, Humans, Lipoproteins, HDL, Risk Factors, Societies, Scientific, Consensus, Molecular Targeted Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

High-density lipoproteins: A consensus statement from the National Lipid Association

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks